The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Clostridium diffcile associated infection, diarrhea andcolitis
Open accessAbstract
A new, hypervirulent strain of Clostridium difficile, called NAP1/BI/027, has been implicated in C. difficile outbreaks associated with increased morbidity and mortality since the early 2000s. The epidemic strain is resistant to fluoroquinolones in vitro, which was infrequent prior to 2001. The name of this strain reflects its characteristics, demonstrated by different typing methods: pulsed-field gel electrophoresis (NAP1), restriction endonuclease analysis (BI) and polymerase chain reaction (027). In 2004 and 2005, the US Centers for Disease Control and Prevention (CDC) emphasized that the risk of C. difficile-associated diarrhea (CDAD) is increased, not only by the usual factors, including antibiotic exposure, but also gastrointestinal surgery/manipulation, prolonged length of stay in a healthcare setting, serious underlying illness, immune-compromising conditions, and aging. Patients on proton pump inhibitors (PPIs) have an elevated risk, as do peripartum women and heart transplant recipients. Before 2002, toxic megacolon in C. difficile-associated colitis (CDAC), was rare, but its incidence has increased dramatically. Up to two-thirds of hospitalized patients may be infected with C. difficile. Asymptomatic carriers admitted to healthcare facilities can transmit the organism to other susceptible patients, thereby becoming vectors. Fulminant colitis is reported more frequently during outbreaks of C. difficile infection in patients with inflammatory bowel disease (IBD). C. difficile infection with IBD carries a higher mortality than without underlying IBD. This article reviews the latest information on C. difficile infection, including presentation, vulnerable hosts and choice of antibiotics, alternative therapies, and probiotics and immunotherapy. We review contact precautions for patients with known or suspected C. difficile-associated disease. Healthcare institutions require accurate and rapid diagnosis for early detection of possible outbreaks, to initiate specific therapy and implement effective control measures. A comprehensive C. difficile infection control management rapid response team (RRT) is recommended for each health care facility. A communication network between RRTs is recommended, in coordination with each country's department of health. Our aim is to convey a comprehensive source of information and to guide healthcare professionals in the difficult decisions that they face when caring for these oftentimes very ill patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Centers for Disease Control and Prevention
(2007) · Encyclopedia of Measurement and Statistics · doi:10.4135/9781412952644.n74 · Cited by 6,444
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Defensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066
Guideline for hand hygiene in health-care settings
Boyce, J. M., & Pittet, D. (2002) · American Journal of Infection Control · doi:10.1067/mic.2002.130391 · Cited by 2,120
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schröder, J. M., Wang, J. M., Howard, O. M. Z., et al. (1999) · Science · doi:10.1126/science.286.5439.525 · Cited by 1,809
Symbiotic bacteria direct expression of an intestinal bactericidal lectin
Cash, H. L., Whitham, C. V., Behrendt, C. L., & Hooper, L. V. (2006) · Science · doi:10.1126/science.1127119 · Cited by 1,432
Warny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., Frost, E., & McDonald, L. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67420-x · Cited by 1,430
Nosocomial Acquisition of Clostridium difficile Infection
McFarland, L. V., Mulligan, M. E., Kwok, R. Y. Y., & Stamm, W. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901263200402 · Cited by 1,326
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
Clostridium difficile Toxins: Mechanism of Action and Role in Disease
Voth, D. E., & Ballard, J. D. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.247-263.2005 · Cited by 1,104
Boyce, J. M., & Pittet, D. (2002) · PubMed · Cited by 1,047
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
(1958) · PubMed · Cited by 978
Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420604 · Cited by 935
Angiogenins: a new class of microbicidal proteins involved in innate immunity
Hooper, L. V., Stappenbeck, T. S., Hong, C. V., & Gordon, J. I. (2003) · Nature Immunology · doi:10.1038/ni888 · Cited by 929
McFarland, L. V. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510480037031 · Cited by 857
Emergence of Clostridium difficile-associated disease in North America and Europe
Kuijper, E. J., Coignard, B., & Tüll, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01580.x · Cited by 855
Teasley, D., Olson, M., Gebhard, R., Gerding, D., Peterson, L., Schwartz, M., & Lee, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91036-x · Cited by 785
Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin
Salzman, N. H., Ghosh, D., Huttner, K. M., Paterson, Y., & Bevins, C. L. (2003) · Nature · doi:10.1038/nature01520 · Cited by 765
Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease
McFarland, L. V., Elmer, G. W., & Surawicz, C. M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05839.x · Cited by 724
Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications
Dallal, R. M., Harbrecht, B. G., Boujoukas, A. J., Sirio, C. A., Farkas, L. M., Lee, K. K., & Simmons, R. L. (2002) · Annals of Surgery · doi:10.1097/00000658-200203000-00008 · Cited by 628
Pepin, J. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050978 · Cited by 606
Narrative Review: The New Epidemic of Clostridium difficile–Associated Enteric Disease
Bartlett, J. G. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00008 · Cited by 599
Yang, D., Biragyn, A., Hoover, D. M., Lubkowski, J., & Oppenheim, J. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104603 · Cited by 572
Impact of Clostridium difficile on Inflammatory Bowel Disease
Issa, M., Vijayapal, A., Graham, M. B., Beaulieu, D. B., Otterson, M. F., Lundeen, S., Skaros, S., Weber, L. R., Komorowski, R. A., Knox, J. F., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.028 · Cited by 570
Riggs, M. M., Sethi, A. K., Zabarsky, T. F., Eckstein, E. C., Jump, R. L. P., & Donskey, C. J. (2007) · Clinical Infectious Diseases · doi:10.1086/521854 · Cited by 550
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. A. (2007) · Cited by 534
Surawicz, C. M., McFarland, L. V., Greenberg, R. N., Rubin, M., Fekety, R., Mulligan, M. E., Garcia, R. J., Brandmarker, S., Bowen, K., Borjal, D., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/318130 · Cited by 529
Incidence of Clostridium difficile Infection in Inflammatory Bowel Disease
Rodemann, J. F., Dubberke, E. R., Reske, K. A., Seo, D. H., & Stone, C. D. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.027 · Cited by 522
Aas, J., Gessert, C. E., & Bakken, J. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367657 · Cited by 518
Wenisch, C., Parschalk, B., Hasenhundl, M., Hirschl, A. M., & Graninger, W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.5.813 · Cited by 505
BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS
Tvede, M., & Rask-Madsen, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92749-9 · Cited by 491
Ananthakrishnan, A. N., McGinley, E. L., & Binion, D. G. (2008) · Gut · doi:10.1136/gut.2007.128231 · Cited by 426
Porter, E. M., Bevins, C. L., Ghosh, D., & Ganz, T. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8412-z · Cited by 423
Clostridium difficile Infection
Kelly, C. P., & LaMont, J. T. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.375 · Cited by 420
Antibiotic-Associated Diarrhea
Bartlett, J. G. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.4.573 · Cited by 414
Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy
Borody, T. J., Warren, E. F., Leis, S., Surace, R., & Ashman, O. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200307000-00012 · Cited by 388
Zilberberg, M. D., Shorr, A. F., & Kollef, M. H. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1406.071447 · Cited by 362
Lamontagne, F., Labb??, A.-C., Haeck, O., Lesur, O., Lalancette, M., Patino, C., Leblanc, M., Laverdi??re, M., & P??pin, J. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000236628.79550.e5 · Cited by 359
Johnson, S., Homann, S. R., Bettin, K. M., Quick, J. N., Clabots, C. R., Peterson, L. R., & Gerding, D. N. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-297 · Cited by 355
Diagnosis and Treatment of Clostridium difficile Colitis
Fekety, R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500010081036 · Cited by 354
Meta-analysis of probiotics for the treatment of irritable bowel syndrome
McFarland, L. V., & Dublin, S. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.2650 · Cited by 341
Riegler, M., Sedivy, R., Pothoulakis, C., Hamilton, G., Zacherl, J., Bischof, G., Cosentini, E., Feil, W., Schiessel, R., & LaMont, J. T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117885 · Cited by 340
Killgore, G., Thompson, A., Johnson, S., Brazier, J., Kuijper, E., Pepin, J., Frost, E. H., Savelkoul, P., Nicholson, B., van den Berg, R. J., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01484-07 · Cited by 337
Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain
Popoff, M. R., Rubin, E. J., Gill, D. M., & Boquet, P. (1988) · Infection and Immunity · doi:10.1128/iai.56.9.2299-2306.1988 · Cited by 327
Rupnik, M., Avesani, V., Janc, M., von Eichel-Streiber, C., & Delmée, M. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.8.2240-2247.1998 · Cited by 323
Johnson, S., Schriever, C., Galang, M., Kelly, C. P., & Gerding, D. N. (2007) · Clinical Infectious Diseases · doi:10.1086/511870 · Cited by 312
Measures to Control and Prevent Clostridium difficile Infection
Gerding, D. N., Muto, C. A., & Owens, Jr. (2008) · Clinical Infectious Diseases · doi:10.1086/521861 · Cited by 311
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008
Kuijper, E. J., Barbut, F., Brazier, J. S., Kleinkauf, N., Eckmanns, T., Lambert, M. L., Drudy, D., Fitzpatrick, F., Wiuff, C., Brown, D. J., et al. (2008) · Eurosurveillance · doi:10.2807/ese.13.31.18942-en · Cited by 287
Bacteriotherapy Using Fecal Flora: Toying With Human Motions
Borody, T. J., Warren, E. F., Leis, S. M., Surace, R., Ashman, O., & Siarakas, S. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000128988.13808.dc · Cited by 283
Leung, D. Y. M., Kelly, C. P., Boguniewicz, M., Pothoulakis, C., LaMont, J. T., & Flores, A. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83393-1 · Cited by 278
Spigaglia, P., & Mastrantonio, P. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.9.3470-3475.2002 · Cited by 277
Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea
Sougioultzis, S., Kyne, L., Drudy, D., Keates, S., Maroo, S., Pothoulakis, C., Giannasca, P. J., Lee, C. K., Warny, M., Monath, T. P., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.004 · Cited by 260
Probiotics for treatment of Clostridium difficile-associated colitis in adults
Pillai, A., & Nelson, R. L. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004611.pub2 · Cited by 251
Nitazoxanide for the Treatment of Clostridium difficile Colitis
Musher, D. M., Logan, N., Hamill, R. J., DuPont, H. L., Lentnek, A., Gupta, A., & Rossignol, J.-F. (2006) · Clinical Infectious Diseases · doi:10.1086/506351 · Cited by 249
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Fenelon, L., Finch, R., Gould, I., Hartman, G., Holmes, A., Ramsay, C., Taylor, E., Wilcox, M., et al. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub2 · Cited by 248
Guideline for hand hygiene in healthcare settings
(2004) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2003.08.016 · Cited by 243
Muto, C. A., Blank, M. K., Marsh, J. W., Vergis, E. N., O'Leary, M. M., Shutt, K. A., Pasculle, A. W., Pokrywka, M., Garcia, J. G., Posey, K., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/522654 · Cited by 241
Jump, R. L. P., Pultz, M. J., & Donskey, C. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01443-06 · Cited by 232
Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine
Savidge, T. C., Pan, W.-H., Newman, P., O’Brien, M., Anton, P. M., & Pothoulakis, C. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00902-8 · Cited by 230
Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection
Warny, M., Vaerman, J. P., Avesani, V, & Delmée, M. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.384-389.1994 · Cited by 230
Peterson, L. R., Manson, R. U., Paule, S. M., Hacek, D. M., Robicsek, A., Thomson, R. B., & Kaul, K. L. (2007) · Clinical Infectious Diseases · doi:10.1086/522185 · Cited by 224
Barbut, F. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45804-0 · Cited by 211
Walsh, S. V., Hopkins, A. M., Chen, J., Narumiya, S., Parkos, C. A., & Nusrat, A. (2001) · Gastroenterology · doi:10.1053/gast.2001.27060 · Cited by 211
McPherson, S., Rees, C. J., Ellis, R., Soo, S., & Panter, S. J. (2006) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0511-8 · Cited by 201
Relapsing Clostridium difficile Enterocolitis Cured by Rectal Infusion of Normal Faeces
Schwan, A., Sjolin, S., Trottestam, U., & Aronsson, B. (1984) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548409087145 · Cited by 201
Localization of human intestinal defensin 5 in Paneth cell granules
Porter, E. M., Liu, L., Oren, A., Anton, P. A., & Ganz, T. (1997) · Infection and Immunity · doi:10.1128/iai.65.6.2389-2395.1997 · Cited by 186
Persky, S. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02095-5 · Cited by 179
Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis.
Bowden, T. A., Ar, M., & Le, L. (1981) · PubMed · Cited by 179
Gordin, F. M., Schultz, M. E., Huber, R. A., & Gill, J. A. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502596 · Cited by 174
McEllistrem, M. C., Carman, R. J., Gerding, D. N., Genheimer, C. W., & Zheng, L. (2005) · Clinical Infectious Diseases · doi:10.1086/427113 · Cited by 173
Coyle, W. J. (2006) · Current Gastroenterology Reports · doi:10.1007/s11894-006-0050-4 · Cited by 171
The Challenges Posed by Reemerging Clostridium difficile Infection
Blossom, D. B., & McDonald, L. C. (2007) · Clinical Infectious Diseases · doi:10.1086/518874 · Cited by 169
Human α-defensins neutralize anthrax lethal toxin and protect against its fatal consequences
KIM, C. S., Gajendran, N., Mittrücker, H., Weiwad, M., Song, Y., HURWITZ, R. M., Wilmanns, M., Fischer, G. S., & Kaufmann, S. H. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500508102 · Cited by 165
Efficacy of Hospital Cleaning Agents and Germicides Against Epidemic Clostridium difficile Strains
Fawley, W. N., Underwood, S., Freeman, J., Baines, S. D., Saxton, K., Stephenson, K., Owens, R. C., & Wilcox, M. H. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/519201 · Cited by 165
Tinidazole: A nitroimidazole antiprotozoal agent
Fung, H. B., & Doan, T.-L. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.12.012 · Cited by 161
Carignan, A., Allard, C., Pépin, J., Cossette, B., Nault, V., & Valiquette, L. (2008) · Clinical Infectious Diseases · doi:10.1086/588291 · Cited by 161
Al‐Nassir, W. N., Sethi, A. K., Nerandzic, M. M., Bobulsky, G. S., Jump, R. L. P., & Donskey, C. J. (2008) · Clinical Infectious Diseases · doi:10.1086/588293 · Cited by 160
The Burden of Clostridium difficile in Surgical Patients in the United States
Zerey, M., Paton, B. L., Lincourt, A. E., Gersin, K. S., Kercher, K. W., & Heniford, B. T. (2007) · Surgical Infections · doi:10.1089/sur.2006.062 · Cited by 158
Kotloff, K. L., Wasserman, S. S., Losonsky, G. A., Thomas, W. D., Nichols, R., Edelman, R., Bridwell, M. W., & Monath, T. P. C. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.988-995.2001 · Cited by 156
The NewClostridium difficile— What Does It Mean?
Bartlett, J. G., & Perl, T. M. (2005) · New England Journal of Medicine · doi:10.1056/nejme058221 · Cited by 153
Update on the changing epidemiology of Clostridium difficile-associated disease
McFarland, L. V. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1029 · Cited by 149
Boyce, J. M., Ligi, C., Kohan, C., Dumigan, D. G., & Havill, N. L. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/504362 · Cited by 148
Proton pump inhibitor therapy is a risk factor for Clostridium difficile ‐associated diarrhoea
YEARSLEY, K. A., GILBY, L. J., Ramadas, A., Kubiak, E., Fone, D. L., & Allison, M. C. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03015.x · Cited by 145
Paneth Cell Defensins and Innate Immunity of the Small Bowel
Ouellette, A. J., & Bevins, C. L. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200102000-00007 · Cited by 141
Outcome of colectomy for Clostridium difficile colitis: a plea for early surgical management
Hall, J. F., & Berger, D. L. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.11.017 · Cited by 139
Wershil, B. K., Castagliuolo, I., & Pothoulakis, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70315-4 · Cited by 135
Clostridium difficile: changing epidemiology and new treatment options
Kuijper, E. J., van Dissel, J. T., & Wilcox, M. H. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32818be71d · Cited by 135
Wheeldon, L. J., Worthington, T., Lambert, P. A., Hilton, A. C., Lowden, C. J., & Elliott, T. S. J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn219 · Cited by 129
Human α-Defensins Inhibit Clostridium difficile Toxin B
Giesemann, T., Guttenberg, G., & Aktories, K. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.008 · Cited by 129
Johal, S. S., Hammond, J., Solomon, K., James, P. D., & Mahida, Y. R. (2004) · Gut · doi:10.1136/gut.2003.028803 · Cited by 129
Drudy, D., Harnedy, N., Fanning, S., et al. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/519181 · Cited by 127
Functional Analysis of the α-Defensin Disulfide Array in Mouse Cryptdin-4
Maemoto, A., Qu, X., Rosengren, K. J., Tanabe, H., Henschen-Edman, A. H., Craik, D. J., & Ouellette, A. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406154200 · Cited by 124
Clostridium difficile toxin A causes early damage to mitochondria in cultured cells
He, D., Hagen, S. J., Pothoulakis, C., Chen, M., Medina, N., Warny, M., & LaMont, J. T. (2000) · Gastroenterology · doi:10.1053/gast.2000.8526 · Cited by 124
In Vitro Activities of OPT-80 and Comparator Drugs against Intestinal Bacteria
Finegold, S. M., Molitoris, D. R., Väisänen, M., Song, Y., Liu, C., & Bolaňos, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4898-4902.2004 · Cited by 122
Clostridium difficile Infection in Patients With Ileal Pouch–Anal Anastomosis
SHEN, B., Jiang, Z., FAZIO, V., REMZI, F., RODRIGUEZ, L., BENNETT, A., López, R., Queener, E. Y., & DuPont, H. L. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.021 · Cited by 119
Clostridium difficile–associated diarrhea: an emerging threat to pregnant women
Rouphael, N., O’Donnell, J. A., Bhatnagar, J., Lewis, F. M. T., Polgreen, P. M., Beekmann, S. E., Guarner, J., Killgore, G., Coffman, B., Campbell, J., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.01.062 · Cited by 119
Aronsson, B., Granström, M., Möllby, R., & Nord, C. E. (1985) · Infection · doi:10.1007/bf01642866 · Cited by 114
Increased diversity of intestinal antimicrobial peptides by covalent dimer formation
Hornef, M. W., Pütsep, K., Karlsson, J., Refai, E., & Andersson, M. (2004) · Nature Immunology · doi:10.1038/ni1094 · Cited by 112
Clostridium difficile infection in patients with unexplained leukocytosis
Wanahita, A., Goldsmith, E. A., Marino, B., & Musher, D. M. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00420-0 · Cited by 112
In Vitro and In Vivo Activities of Nitazoxanide against Clostridium difficile
McVay, C. S., & Rolfe, R. D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2254-2258.2000 · Cited by 111
Factors Associated With Failure of Metronidazole in Clostridium difficile–associated Disease
Fernandez, A. A., Anand, G., & Friedenberg, F. K. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200405000-00005 · Cited by 111
Fulminant Clostridium difficile colitis
Adams, S. D., & Mercer, D. (2007) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3282638879 · Cited by 110
Clostridium difficile Skin Contamination in Patients with C. difficile-Associated Disease
Bobulsky, G. S., Al‐Nassir, W. N., Riggs, M. M., Sethi, A. K., & Donskey, C. J. (2007) · Clinical Infectious Diseases · doi:10.1086/525267 · Cited by 108
Simango, C., & Mwakurudza, S. (2008) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2008.03.020 · Cited by 106
Clostridium Difficile-Associated Diarrhea
Schroeder, M. S. (2012) · SpringerReference · doi:10.1007/springerreference_305381 · Cited by 105
O'Connor, D. E., Hynes, P., Cormican, M., Collins, E., Corbett-Feeney, G., & Cassidy, M. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.8.2846-2849.2001 · Cited by 104
Freeman, J., Baines, S. D., Saxton, K., & Wilcox, M. H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm113 · Cited by 103
The Paneth cell and the innate immune response
Bevins, C. L. (2004) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200411000-00012 · Cited by 101
Association of proton-pump inhibitors with outcomes inClostridium difficilecolitis
Cadle, R. M., Mansouri, M. D., Logan, N. D., Kudva, D. R., & Musher, D. M. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060629 · Cited by 101
Successful Treatment of Fulminant Clostridium difficile Infection with Fecal Bacteriotherapy
You, D. M., Franzos, M. A., & Holman, R. P. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-8-200804150-00024 · Cited by 99
Backman, C., Zoutman, D., & Marck, P. (2008) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.08.007 · Cited by 99
Drudy, D., Quinn, T., O’Mahony, R., Kyne, L., Gaora, P. Ó., & Fanning, S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl398 · Cited by 96
Revised nomenclature of Clostridium difficile toxins and associated genes
Rupnik, M. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45810-0 · Cited by 96
Recurrent Clostridium difficilediarrhoea
Kyne, L., & Kelly, C. P. (2001) · Gut · doi:10.1136/gut.49.1.152 · Cited by 93
Turgeon, D. K., Novicki, T. J., Quick, J., Carlson, L. C., Miller, P. D., Ulness, B. K., Cent, A., Ashley, R. L., Larson, A., Coyle, M. B., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.2.667-670.2003 · Cited by 91
Bettin, K. M., Clabots, C., Mathie, P., et al. (1994) · Infection Control and Hospital Epidemiology · doi:10.1086/646840 · Cited by 90
Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination
Tedesco, F. J. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90280-4 · Cited by 88
Muñóz, P., Giannella, M., Alcalá, L., Sarmiento, E., Yañez, J. F., Palomo, J., Catalán, P., Carbone, J., & Bouza, E. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.07.010 · Cited by 88
Gustafsson, A. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850171666 · Cited by 88
Wang, W., Mulakala, C., Ward, S. C., Jung, G., Luong, H. T., Pham, D. S. L., Waring, A. J., Kaznessis, Y. N., Lu, W., Bradley, K. A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603614200 · Cited by 85
Segarra‐Newnham, M. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k110 · Cited by 83
Lundeen, S. J., Otterson, M. F., Binion, D. G., Carman, E. T., & Peppard, W. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-006-0022-x · Cited by 81
Gant, V. A., Wren, M. W. D., Rollins, M. S. M., Jeanes, A., Hickok, S. S., & Hall, T. J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm201 · Cited by 76
Shin, B.-M., Kuak, E. Y., Yoo, S. J., Shin, W. C., & Yoo, H. M. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.10.022 · Cited by 73
Stabler, R. A., Dawson, L. F., Phua, L. T. H., & Wren, B. W. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47743-0 · Cited by 69
Pankuch, G. A., & Appelbaum, P. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1112-1117.2006 · Cited by 69
Vanpoucke, H. J. M., Baere, T. D., Claeys, G., Vaneechoutte, M., & Verschraegen, G. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2001.00141.x · Cited by 67
PROTEIN-LOSING ENTEROPATHY ASSOCIATED WITH CLOSTRIDIUM DIFFICILE INFECTION
Rybolt, A., Laughon, B. E., Greenough, W., Bennett, R., Thomas, D., & Bartlett, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92803-1 · Cited by 66
[Clostridium difficile-associated diarrhea treated with homologous feces].
Lund-Tønnesen, S., Berstad, A., Schreiner, A., & Midtvedt, T. (1998) · PubMed · Cited by 58
Shin, B.-M., Kuak, E. Y., Yoo, H. M., Kim, E. C., Lee, K., Kang, J. O., Whang, D. H., & Shin, J.-H. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47771-0 · Cited by 56
Ileal Perforation Secondary to Clostridium difficile Enteritis
Hayetian, F. D. (2006) · Archives of Surgery · doi:10.1001/archsurg.141.1.97 · Cited by 55
Colonoscopy in the Diagnosis of Antibiotic-Associated Colitis
Seppälä, K., Hjelt, L. H., & Sipponen, P. (1981) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528109181999 · Cited by 54
Taylor, C. P., Tummala, S., Molrine, D. C., Davidson, L. E., Farrell, R. J., Lembo, A. J., Hibberd, P. L., Lowy, I., & Kelly, C. P. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.042 · Cited by 54
Modena, S., Gollamudi, S., & Friedenberg, F. K. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000190761.80615.0f · Cited by 52
Kokkotou, E. G., Moss, A. C., Michos, A. G., Espinoza, D., Cloud, J. W., Mustafa, N., O’Brien, M. J., Pothoulakis, C., & Kelly, C. P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01143-07 · Cited by 51
Gerber, M., & Ackermann, G. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.4.547 · Cited by 51
Defensins and Other Antimicrobial Peptides and Proteins
Lehrer, R. I., Bevins, C. L., & Ganz, T. (2005) · Elsevier eBooks · doi:10.1016/b978-012491543-5/50010-3 · Cited by 51
"flora power"-fecal bacteria cure chronic C. difficile diarrhea
Borody, T. J. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03277.x · Cited by 50
Dansinger, M. L., Johnson, S., Jansen, P. C., Opstad, N. L., Bettin, K. M., & Gerding, D. N. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.6.932 · Cited by 47
Antibiotic-Associated Diarrhea: Candidate Organisms other than Clostridium Difficile
Song, H. J., Shim, K., Jung, S.-A., Choi, H. J., Lee, M. A., Ryu, K. H., Kim, S., & Yoo, K. (2008) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2008.23.1.9 · Cited by 47
Treatment of recurrent Clostridium difficile-associated disease
Surawicz, C. M. (2004) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0018 · Cited by 43
Hinkson, P. L., Dinardo, C., DeCiero, D., Klinger, J. D., & Barker, R. H. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00041-08 · Cited by 42
Defensin: a multifunctional molecule lives up to its versatile name
KIM, C. S., & Kaufmann, S. H. E. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.08.001 · Cited by 41
Clostridium Difficile Infection After Total Joint Arthroplasty: Who is at Risk?
Kurd, M. F., Pulido, L. F., Joshi, A., Purtill, J. J., & Parvizi, J. (2008) · The Journal of Arthroplasty · doi:10.1016/j.arth.2007.10.033 · Cited by 32
Actualités sur les infections à Clostridium difficile
Blanckaert, K., Coignard, B., Grandbastien, B., Astagneau, P., & Barbut, F. (2007) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2007.09.029 · Cited by 30
Jank, T., Ziegler, M. O. P., Schulz, G. E., & Aktories, K. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.05.025 · Cited by 27
Inflammatory Bowel Disease and Clostridium difficile–Associated Diarrhea: A Growing Problem
Tremaine, W. J. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.030 · Cited by 24
Hookman, P., & Barkin, J. S. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9450-4 · Cited by 23
Self-citation[Refractory Clostridium difficile infection. Untraditional treatment of antibiotic-induced colitis].
Fløtterød, Ø., & Hopen, G. (1991) · PubMed · Cited by 21
Diagnostic and treatment delays in recurrent clostridium difficile–associated disease
Scheurer, D. B. (2008) · Journal of Hospital Medicine · doi:10.1002/jhm.277 · Cited by 19
“flora power”—fecal bacteria cure chronic C. difficile diarrhea
Borody, T. J. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02070-0 · Cited by 16
Altes und Neues zur antibiotikaassoziierten Diarrhö
Cramer, J. P., Burchard, G. D., & Lohse, A. W. (2008) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-008-1040-0 · Cited by 11
Clinical and Epidemiological Aspects of Clostridium difficile
Oughton, M., & Miller, M. A. (2008) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2008.05.004 · Cited by 9
Cited by
Gough, E., Shaikh, H., & Manges, A. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir632 · Cited by 1,003
Electrochemical biosensors for pathogen detection
Cesewski, E., & Johnson, B. N. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112214 · Cited by 902
Clostridium difficile infection: review
Czepiel, J., Dróżdż, M., Pituch, H., Kuijper, E. J., Perucki, W., Mielimonka, A., Goldman, S., Wultańska, D., Garlicki, A., & Biesiada, G. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03539-6 · Cited by 702
Collado, M. C., Isolauri, E., Laitinen, K., & Salminen, S. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29877 · Cited by 381
Herbert, M. R. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328336a01f · Cited by 356
Metadata
- Authors
- Hookman, P., & Barkin, J. S.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2009
- Volume
- 15
- Issue
- 13
- Pages
- 1554
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W1992379400
- Cited by
- 275
- References
- 159
- FWCI
- 20.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.